Bicycle Therapeutics earnings were -$190.4M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest BCYC earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$50.3M, down 17.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BCYC reported annual earnings of -$219.0M, with 29.5% growth. The next BCYC earnings date is Aug 14, 2026.
Bicycle Therapeutics Earnings Reports & History FAQ
What were Bicycle Therapeutics's earnings last quarter?
On BCYC's earnings call on Aug 14, 2026, Bicycle Therapeutics (NASDAQ: BCYC) reported Q2 2026 earnings per share (EPS) of -$0.72, up 36.84% year over year. Total BCYC earnings for the quarter were -$50.33 million. In the same quarter last year, Bicycle Therapeutics's earnings per share (EPS) was -$1.14.
The next BCYC earnings call is Aug 14, 2026. Add BCYC to your watchlist to be reminded of Bicycle Therapeutics's next earnings date.
Is Bicycle Therapeutics profitable or losing money?
As of the last Bicycle Therapeutics earnings report, Bicycle Therapeutics is currently losing money. Bicycle Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$190.41 million, a 21.43% decrease year over year.
What was BCYC's earnings growth in the past year?
As of Bicycle Therapeutics's earnings date in Aug 14, 2026, Bicycle Therapeutics's earnings has grown year over year. BCYC earnings in the past year totalled -$190.41 million.
What are Bicycle Therapeutics's earnings expectations?
The current EPS estimate for Bicycle Therapeutics's earnings report in Aug 14, 2026 is -$0.37.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.